Literature DB >> 8902714

Contractile properties of myocardium are altered in dystrophin-deficient mdx mice.

J L Sapp1, J Bobet, S E Howlett.   

Abstract

The objective of this study was to determine whether cardiac contractile force is altered in the dystrophin-deficient mdx mouse model of muscular dystrophy. Left atria from 12-14-week-old control and mdx mice were paced at 1 Hz in 1.25 mM external Ca2+ buffer. Twitch properties and effects of interposing intervals of 0.3 to 600 s on the force of subsequent beats (force-interval curves) were examined. Peak force and time-to-peak force were similar in both groups, but half-relaxation time was significantly prolonged in mdx heart. In control hearts, force-interval curves increased to an inflection point at about 1 s, then rose to a second peak near 60 s. In mdx heart, curves reached the early inflection more quickly, the second peak was diminished in magnitude and force was greatly depressed at long intervals. Curves were fitted to a four-parameter equation to quantify differences in shape. The parameter a, which reflects rate of rise to the first inflection, was significantly increased in mdx atria, while the parameter B, which reflects amplitude of the late peak, was significantly reduced. These differences in force production were more marked when external Ca2+ was raised to 2.5 mM. Results show contractile properties are markedly altered in atria from dystrophin-deficient mdx mice. These findings are consistent with the hypothesis that dystrophin deficiency affects cardiac contractile function, possibly through effects on SR function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902714     DOI: 10.1016/0022-510x(96)00167-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts.

Authors:  Ya-Jian Cheng; Di Lang; Shelton D Caruthers; Igor R Efimov; Junjie Chen; Samuel A Wickline
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-09       Impact factor: 4.733

Review 2.  Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.

Authors:  Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

3.  Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics.

Authors:  V Nicolas-Metral; E Raddatz; P Kucera; U T Ruegg
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.

Authors:  Daniel P Reay; Gabriela A Niizawa; Jon F Watchko; Molly Daood; Ja'Nean C Reay; Eugene Raggi; Paula R Clemens
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

5.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

6.  NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy.

Authors:  Daniel R Gonzalez; Adriana V Treuer; Guillaume Lamirault; Vera Mayo; Yenong Cao; Raul A Dulce; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

7.  Cardiac electrophysiological characteristics of the mdx ( 5cv ) mouse model of Duchenne muscular dystrophy.

Authors:  Dorothy M Branco; Cordula M Wolf; Megan Sherwood; Peter E Hammer; Peter B Kang; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2007-10-17       Impact factor: 1.900

8.  Deficiency in Cardiac Dystrophin Affects the Abundance of the $\alpha$ -/ $\beta$ -Dystroglycan Complex.

Authors:  James Lohan; Kevin Culligan; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2005

9.  The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration.

Authors:  Sören Wagner; Stephan Knipp; Cornelia Weber; Selina Hein; Stefanie Schinkel; Andreas Walther; Raffi Bekeredjian; Oliver J Müller; Oliver Friedrich
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

10.  Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model.

Authors:  Rachel T Sullivan; Ngoc T Lam; Margaret Haberman; Margaret J Beatka; Muhammad Z Afzal; Michael W Lawlor; Jennifer L Strande
Journal:  BMC Cardiovasc Disord       Date:  2021-06-15       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.